ADPT
NASDAQ · Life Sciences Tools & Services
Adaptive Biotechnologies
$28.61
+0.06 (+0.21%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+201.3% upside
Low Target
$68.90
Average Target
$86.20
High Target
$131.13
Current Price
$28.61
Current
$28.61
$28.61
Target
$86.20
$86.20
$68.90
$86.20 avg
$131.13
Scenario Analysis
Bear Case
$68.90
140.8%
Low target
Base Case
$86.20
+201.3%
Avg target
Bull Case
$131.13
+358.3%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$28.72
-0.4% from high
52-Week Low
$12.00
+138.4% from low
50-Day SMA
$16.81
+70.2% vs SMA
200-Day SMA
$13.88
+106.1% vs SMA
RSI (14)
24.2
Oversold
Target vs 52W High
$86.20
+200.1% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 36 | 81% | $369.21 | -43.9% |
| DHR | Strong Buy | 32 | 84% | $158.11 | -28.5% |
| IQV | Strong Buy | 28 | 82% | $82.96 | -69.3% |
| A | Strong Buy | 30 | 77% | $64.69 | -61.3% |
| WAT | Buy | 31 | 65% | $189.60 | -55.5% |
| ILMN | Buy | 28 | 57% | $169.36 | -31.6% |
| MTD | Hold | 19 | 53% | $170.43 | -88.6% |
| WST | Strong Buy | 23 | 91% | $136.24 | -63.3% |